Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans

Scand J Immunol. 1998 Aug;48(2):116-23. doi: 10.1046/j.1365-3083.1998.00396.x.


Mannan-binding lectin (MBL, previously named mannan-binding protein, MBP) is a serum collectin, which activates complement upon binding to microbial carbohydrates. This results in opsonization of the microorganisms as well as direct complement-mediated killing. Clinical evidence indicates that MBL has an important role in the innate immune defence against various pathogens. Genetically determined MBL deficiency is associated with increased susceptibility to infections. We have infused two MBL-deficient individuals with clinical grade MBL, purified from pooled donor plasma, in doses sufficient to attain normal concentration of MBL in serum. This resulted in normalization of complement-mediated opsonization. An initial rapid decrease in the serum concentration of MBL was followed by a slower decline with an estimated half-life of about 6 days. No adverse effects were observed and anti-MBL antibodies could not be detected following several MBL infusions. One of the two MBL recipient, a two-year-old girl, who had been suffering from repeated infections from the age of 4 months, was given a total of six MBL infusions. She has subsequently remained healthy for more than three years.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carrier Proteins / administration & dosage
  • Carrier Proteins / therapeutic use*
  • Child, Preschool
  • Collectins
  • Drug Stability
  • Female
  • Humans
  • Immunologic Deficiency Syndromes / therapy*
  • Lectins
  • Male
  • Mannans
  • Opsonin Proteins / immunology*


  • Carrier Proteins
  • Collectins
  • Lectins
  • Mannans
  • Opsonin Proteins